相似文献
1
In vitro activities of LY163892, cefaclor, and cefuroxime.LY163892、头孢克洛和头孢呋辛的体外活性。
Antimicrob Agents Chemother. 1988 Jan;32(1):131-3. doi: 10.1128/AAC.32.1.131.
2
[Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].头孢泊肟、头孢呋辛和头孢克洛对严格厌氧菌的抗菌活性比较
Pathol Biol (Paris). 1990 May;38(5):343-6.
3
In vitro activity and beta-lactamase stability of LY163892.LY163892的体外活性及β-内酰胺酶稳定性
Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):549-51. doi: 10.1007/BF01962613.
4
Comparative in-vitro activity of a new oral carbacephem, LY163892.
J Antimicrob Chemother. 1988 Oct;22(4):445-56. doi: 10.1093/jac/22.4.445.
5
Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.氨苄西林、头孢噻吩、头孢克洛和头孢呋辛对流感嗜血杆菌侵袭性分离株的抗菌活性及药敏试验考量
Chemotherapy. 1989;35(2):88-94. doi: 10.1159/000238653.
6
Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.储存及药敏试验条件对LY163892及其他四种头孢菌素稳定性和活性的影响
Antimicrob Agents Chemother. 1988 Oct;32(10):1477-80. doi: 10.1128/AAC.32.10.1477.
7
Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae.
Pharmacotherapy. 1997 Mar-Apr;17(2):235-41.
8
Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
J Antimicrob Chemother. 1988 Sep;22(3):315-20. doi: 10.1093/jac/22.3.315.
9
In-vitro activity and beta-lactamase stability of LY163892.
J Antimicrob Chemother. 1988 Aug;22(2):155-65. doi: 10.1093/jac/22.2.155.
10
In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.头孢克洛、头孢氨苄和氨苄西林对2458株流感嗜血杆菌临床分离株的体外活性。
J Antimicrob Chemother. 1988 Jan;21(1):27-31. doi: 10.1093/jac/21.1.27.
引用本文的文献
1
Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.头孢呋辛酯。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1996 Jul;52(1):125-58. doi: 10.2165/00003495-199652010-00009.
2
Prophylaxis with oral cefadroxil versus intravenous cefuroxime in trochanteric fracture surgery. A clinical multicentre study.口服头孢羟氨苄与静脉注射头孢呋辛预防粗隆间骨折手术感染的临床多中心研究
Arch Orthop Trauma Surg. 1995;114(6):303-7. doi: 10.1007/BF00448952.
3
Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.头孢呋辛酯短程疗法（5天）治疗急性支气管炎继发细菌感染的疗效
Antimicrob Agents Chemother. 1995 Nov;39(11):2528-34. doi: 10.1128/AAC.39.11.2528.
4
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.氯碳头孢。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1993 May;45(5):716-36. doi: 10.2165/00003495-199345050-00008.
5
Pharmacokinetics of LY163892 in infants and children.LY163892在婴幼儿和儿童中的药代动力学。
Antimicrob Agents Chemother. 1988 Nov;32(11):1738-9. doi: 10.1128/AAC.32.11.1738.
6
Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.储存及药敏试验条件对LY163892及其他四种头孢菌素稳定性和活性的影响
Antimicrob Agents Chemother. 1988 Oct;32(10):1477-80. doi: 10.1128/AAC.32.10.1477.
7
In vitro activity and beta-lactamase stability of LY163892.LY163892的体外活性及β-内酰胺酶稳定性
Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):549-51. doi: 10.1007/BF01962613.
8
Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.几种新型氟喹诺酮类和β-内酰胺类抗菌药物对社区分离肺炎链球菌的体外活性比较
Antimicrob Agents Chemother. 1990 Mar;34(3):467-9. doi: 10.1128/AAC.34.3.467.
9
Loracarbef versus cefaclor in the treatment of urinary tract infections in women.氯碳头孢与头孢克洛治疗女性尿路感染的比较。
Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750.
10
Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams.氯碳头孢（LY 163892）在血清中的杀菌效价以及接受400毫克与200毫克剂量的志愿者中的杀菌率。
Antimicrob Agents Chemother. 1992 Mar;36(3):521-6. doi: 10.1128/AAC.36.3.521.
本文引用的文献
1
Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.头孢呋辛1-乙酰氧基乙酯在志愿者体内的药理学研究
Antimicrob Agents Chemother. 1984 Jan;25(1):78-82. doi: 10.1128/AAC.25.1.78.
2
Influence of beta-lactamase-producing strains of Branhamella catarrhalis and Haemophilus influenzae on certain beta-lactam antibiotics.产β-内酰胺酶的卡他莫拉菌和流感嗜血杆菌菌株对某些β-内酰胺类抗生素的影响
J Antimicrob Chemother. 1983 Sep;12(3):269-71. doi: 10.1093/jac/12.3.269.
3
Cefuroxime - a new cephalosporin antibiotic.头孢呋辛——一种新型头孢菌素类抗生素。
J Antibiot (Tokyo). 1976 Jan;29(1):29-37. doi: 10.7164/antibiotics.29.29.
4
Cefaclor: in vitro spectrum of activity and beta-lactamase stability.头孢克洛：体外活性谱及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1978 Apr;13(4):584-8. doi: 10.1128/AAC.13.4.584.
5
Comparative beta-lactamase resistance and antistaphylococcal activities of parenterally and orally administered cephalosporins.
J Infect Dis. 1978 Apr;137(4):490-3. doi: 10.1093/infdis/137.4.490.
6
Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.头孢氨苄、头孢拉定和头孢克洛的体外活性比较。
Antimicrob Agents Chemother. 1977 Mar;11(3):470-4. doi: 10.1128/AAC.11.3.470.
7
Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.头孢呋辛，一种对β-内酰胺酶稳定的头孢菌素，具有广谱的革兰氏阳性和阴性菌活性。
Antimicrob Agents Chemother. 1978 Apr;13(4):657-64. doi: 10.1128/AAC.13.4.657.
8
Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.新型口服头孢菌素抗生素头孢克洛的稳定性及血药浓度测定
Antimicrob Agents Chemother. 1978 Jan;13(1):49-52. doi: 10.1128/AAC.13.1.49.
Zotero 插件